HOLX vs INM · P/E 32, rev $4.10B vs rev $4.9M
Hologic Inc (HOLX) versus InMed Pharmaceuticals Inc (INM) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. INM currently screens at market cap $5.2M.
Not investment advice. Open the HOLX and INM stock pages for the full models.
Not investment advice.